Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.9T | 7.4T | 7.0T | 7.0T |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 2.9T | 2.1T | 2.7T | 2.4T |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.5T | 2.4T | 2.1T | 1.8T |
| Tax provision | 698.9B | 743.9B | 590.2B | 363.3B |
| Net income | 1.8T | 1.7T | 1.5T | 1.5T |
| Basic EPS | 7.3K | 6.9K | 6.2K | 6.0K |
| Diluted EPS | 7.3K | 6.9K | 6.2K | 6.0K |
| Basic average shares | 997.6B | 1.0T | 1.0T | 533.5B |
| Diluted average shares | 997.6B | 1.0T | 1.0T | 533.5B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | 1.7T | 1.5T | 1.5T |
| Minority interests | -27.1B | -36.0B | -18.3B | -22.0B |
| Preferred stock dividends | — | — | — | — |